Top compounds associated with response to RP11-347C12.1


Feature Type Standardized
Nominal ANOVA
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 4e-07
mRNA nelarabine CTRPv2 pan-cancer AAC 0.21 1e-06
mRNA dexamethasone CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.15 3e-06
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC 0.15 3e-06
mRNA pac-1 CTRPv2 pan-cancer AAC 0.18 4e-06
mRNA barasertib CTRPv2 pan-cancer AAC 0.15 3e-05
mRNA clofarabine CTRPv2 pan-cancer AAC 0.13 4e-05
mRNA BRD-A86708339 CTRPv2 pan-cancer AAC 0.23 5e-05
mRNA SN-38 CTRPv2 pan-cancer AAC 0.16 7e-05
Download CSV